Table 3 Substrate scope for the enantioselective F–C reactionsa
avenue to construct a controllable DNA metalloenzyme for
chemical and enzymatic synthesis using the accessible DNA.
We thank Prof. Z. Feng, Prof. Q. Yang and Dr J. Li for
their helpful discussions. This work was supported by the
NSFC (20773123, 20621063, 31000392).
Entry
1
2
3
Conversionb (%)
eec (%)
1
2
3
4
5
6
7
8
9
1a
1a
1a
1a
1a
1b
1c
1d
1e
2a
2b
2c
2d
2e
2a
2a
2a
2a
3a
3b
3c
3d
3e
3f
3g
3h
3i
99
99
99
93
99
91
61
72
37
75
67
66
8
44
21
7
Notes and references
1 (a) T. B. Poulsen and K. A. Jørgensen, Chem. Rev., 2008,
108, 2903; (b) S. L. You, Q. Cai and M. Zeng, Chem. Soc. Rev.,
2009, 38, 2190.
7
9
2 (a) K. B. Jensen, J. Thorhauge, R. G. Hazell and K. A. Jørgensen,
Angew. Chem., Int. Ed., 2001, 40, 160; (b) N. A. Paras and
D. W. C. MacMillan, J. Am. Chem. Soc., 2001, 123, 4370;
(c) W. Zhuang, T. Hansen and K. A. Jørgensen, Chem. Commun.,
2001, 347; (d) D. A. Evans, K. A. Scheidt, K. R. Fandrick,
H. W. Lam and J. Wu, J. Am. Chem. Soc., 2003, 125, 10780;
(e) D. A. Evans, K. R. Fandrick and H. J. Song, J. Am. Chem.
Soc., 2005, 127, 8942; (f) D. A. Evans, K. R. Fandrick, H. J. Song,
K. A. Scheidt and R. Xu, J. Am. Chem. Soc., 2007, 129, 10029;
(g) B. M. Trost and C. Muller, J. Am. Chem. Soc., 2008, 130, 2438;
(h) Y. Liu, D. Shang, X. Zhou, Y. Zhu, L. Lin, X. Liu and X. Feng,
Org. Lett., 2010, 12, 180; (i) Q. Yin and S. L. You, Chem. Sci.,
2011, 2, 1344.
3 (a) J. Zhou, M. C. Ye, Z. Z. Huang and Y. Tang, J. Org. Chem.,
2004, 69, 1309; (b) H. Ube, S. Fukuchi and M. Terada,
Tetrahedron: Asymmetry, 2010, 21, 1203; (c) F. Guo, D. Chang,
G. Lai, T. Zhu, S. Xiong, S. Wang and Z. Wang, Chem.–Eur. J.,
2011, 17, 11127.
4 A. J. Boersma, B. L. Feringa and G. Roelfes, Angew. Chem., Int.
Ed., 2009, 48, 3346.
5 (a) A. J. Boersma, R. P. Megens, B. L. Feringa and G. Roelfes,
Chem. Soc. Rev., 2010, 39, 2083; (b) S. K. Silverman, Angew.
Chem., Int. Ed., 2010, 49, 7180; (c) T. R. Ward, Acc. Chem. Res.,
2011, 44, 47.
a
Reaction conditions: 1 (1 mmol, 1 eq.), 2 (5 eq.), ODN-1 (0.1 eq.),
Cu(NO3)2 (0.05 eq.), NaCl (50 mM), MOPS buffer (20 mM, pH 6.5),
4 1C, 24 h. Determined by 1H-NMR for the crude product averaged
b
c
by two experiments. Reproducible within ꢀ10%. Determined by
chiral-phase HPLC. Reproducible within ꢀ5%.
(loop sequence AAA) and ODN-6–Cu2+ (loop sequence
AAT) provide the product 3a in the reversed configuration
of 7% ee, 6% ee, 17% ee and 16% ee, respectively (Table 2,
entries 3–6). Minor mutations in the loop sequence of G4DNA
can have a great effect on the enantioselective F–C reaction,
which strongly suggests that the loop sequence plays a crucial
role in the chiral induction of the reaction.13 Compared to
ODN-1–Cu2+, non-structured 21-mer oligodeoxynucleotides
containing d(TTA) combining with Cu2+ ions show the
racemic products, indicating that the G-quadruplex structure
is essential for the enantioselective F–C reaction (Table S3,
ESIw).
Various substituted 2-acylimidazoles (1a–e) and substituted
indoles (2a–e) were tested for the enantioselective F–C reac-
tions catalyzed by ODN-1–Cu2+. We were pleased to find that
the ODN-1–Cu2+ could provide nearly full conversions for the
F–C reactions with 2-acylimidazole (1a) and a variety of
substituted indoles (2a–e). Compared to the F–C reaction
between 1a and indole (2b) that generates 67% ee (Table 3,
entry 2), the reactions with 1a and 5-methoxy indole (2a) and
5-chloro indole (2c) provide the corresponding product 3a in
75% ee and 3c in 66% ee (Table 3, entries 1 and 3), which
indicates that the electronic effect of the substitute substantially
influences the F–C reaction. In addition, substituted indoles
such as 1-methyl indole (2d) and 2-methyl indole (2e) reacted
with 1a to generate the corresponding products in 8% ee and
44% ee, respectively (Table 3, entries 4 and 5). Moreover,
2-acylimidazoles with aromatic moieties (1b–e) reacted with
2a yield the corresponding F–C products in low enantio-
selectivities (Table 3, entries 6–9). Compared to the F–C reaction
between 1b and 2a (Table 3, entry 6), the 2-acylimidazoles with
another substituent (p-Br, p-Cl and p-MeO) in the aromatic
moiety of R1 reacted with 2a yield the corresponding F–C
products with decreased activities and enantioselectivities.
In summary, we found that human telomeric G4DNA can
serve as a direct chiral catalyst for the enantioselective F–C
reaction. When a G4DNA metalloenzyme is derived from
Cu2+ ions and G4DNA, the activity and the enantioselectivity
of the F–C reaction are considerably enhanced. Furthermore,
we found that the absolute configuration and the enantio-
selectivity of the product are sensitive to the DNA sequence,
and the loop sequence in the G4DNA metalloenzyme plays an
important role in the chiral expression. This work opens a new
6 (a) G. Roelfes and B. L. Feringa, Angew. Chem., Int. Ed., 2005,
44, 3230; (b) D. Coquiere, B. L. Feringa and G. Roefles, Angew.
Chem., Int. Ed., 2007, 46, 9308; (c) N. Shibata, H. Yasui,
S. Nakamura and T. Toru, Synlett, 2007, 1153; (d) E. W. Dijk,
B. L. Feringa and G. Roelfes, Tetrahedron: Asymmetry, 2008,
19, 2374; (e) P. Fournier, R. Fiammengo and A. Jaschke, Angew.
Chem., Int. Ed., 2009, 48, 4426; (f) S. Roe, D. J. Ritson, T. Garner,
M. Searle and J. E. Moses, Chem. Commun., 2010, 46, 4309;
(g) A. J. Boersma, D. Coquiere, D. Geerdink, F. Rosati,
B. L. Feringa and G. Roelfes, Nat. Chem., 2010, 2, 991.
7 Quadruplex Nucleic Acids, ed. S. Neidle and S. Balasubramanian,
RSC publishing, Cambridge, 2006.
8 (a) Z. Tang and A. Marx, Angew. Chem., Int. Ed., 2007, 46, 7297;
(b) Z. Tang, D. P. N. Goncalves, M. Wieland, A. Marx and
J. S. Hartig, ChemBioChem, 2008, 9, 1061; (c) S. A. McManus
and Y. Li, J. Mol. Biol., 2008, 375, 960; (d) S. Nakayama, J. Wang
and H. O. Sintim, Chem.–Eur. J., 2011, 17, 5691.
9 Y. Wang and D. J. Patel, Structure, 1993, 1, 263.
10 A. M. Pyle, Science, 1993, 261, 709.
11 (a) A. Ambrus, D. Chen, J. Dai, T. Bialis, R. A. Jones and
D. Yang, Nucleic Acids Res., 2006, 34, 2723; (b) K. N. Luu,
A. T. Phan, V. Kuryavyi, L. Lacroix and D. J. Patel, J. Am. Chem.
Soc., 2006, 128, 9963; (c) Y. Xu, Y. Noguchi and H. Sugiyama,
Bioorg. Med. Chem., 2006, 14, 5584; (d) J. Dai, M. Carver,
C. Punchihewa, R. A. Jones and D. Yang, Nucleic Acids Res.,
2007, 35, 4927; (e) A. T. Phan, V. Kuryavyi, K. N. Luu and
D. J. Patel, Nucleic Acids Res., 2007, 35, 6517; (f) K. W. Lim,
S. Amrane, S. Bouaziz, W. Xu, Y. Mu, D. J. Patel, K. N. Luu and
A. T. Phan, J. Am. Chem. Soc., 2009, 131, 4301.
12 (a) Y. Xue, Z. Y. Kan, Q. Wang, Y. Yao, J. Liu, Y. H. Hao and
Z. Tan, J. Am. Chem. Soc., 2007, 129, 11185; (b) J. Zhou, C. Wei,
G. Jia, X. Wang, Q. Tang, Z. Feng and C. Li, Biophys. Chem.,
2008, 136, 124; (c) B. Heddi and A. T. Phan, J. Am. Chem. Soc.,
2011, 133, 9824; (d) L. Petraccone, A. Malafronte, J. Amato and
C. Giancola, J. Phys. Chem. B, 2012, 116, 2294.
13 (a) H. Yu, X. Wang, M. Fu, J. Ren and X. Qu, Nucleic Acids Res.,
2008, 36, 5695; (b) H. Yu, C. Zhao, Y. Chen, M. Fu, J. Ren and
X. Qu, J. Med. Chem., 2010, 53, 492; (c) C. Zhao, J. Geng, L. Feng,
J. Ren and X. Qu, Chem.–Eur. J., 2011, 17, 8209.
c
6234 Chem. Commun., 2012, 48, 6232–6234
This journal is The Royal Society of Chemistry 2012